STUDIES HIGHLIGHTED IN THIS EPISODE
Qui Y et al (starts at 2:41). Systematic Review and Meta-analysis of the Association Between Metabolic Syndrome and Androgenetic Alopecia. Acta Derm Venereol. 2022 Feb 8;102:adv00645
 
Gupta AK et al (starts at 8:38). Relative Efficacy of Minoxidil and the 5-alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis. JAMA Dermatol. 2022 Feb 2:e215743
 
Plante J (starts at 23:13). Perifollicular inflammation and follicular spongiosis in androgenetic alopecia. J Am Acad Dermatol 2022Feb;86(2):437-438.
 
Qiu et al (starts at 28:04). Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients. Lasers Med Sci. 2022
 
Yale K et al (starts at 33:53). A year in review: A cross-sectional study of alopecia areata and risk of COVID-19 infection, hospitalization, and mortality from March 2020 -February 2021 Int J Dermatol. 2022 Mar;61(3):e81-e83.
 
Lee MM (starts at 38:10). Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity? Int J Dermatol. 2022 Feb
 
Bardazzi et al (starts at 39:04). New insights on alopecia areata during COVID-19 pandemic: when infection or vaccination seems to play a role. J Cosmet Dermatol. 2022 Feb 188.
 
Scollan M et al (starts at 41:08). Alopecia areata after SARS-CoV-2 vaccination JAAD Case Rep. 2022 Feb;20:1-5.
 
Harries M et al (starts at 43:42). The epidemiology of alopecia areata: a population-based cohort study in UK primary care. Br J Dermatol. 2022 Feb;186(2):257-265.
 
Gutierrez Y et al (starts at 49:38). Alopecia areata in the United States: a ten-year analysis of patient characteristics, comorbidities, and treatment patterns. Dermatol Online J. 2021 Oct 15;27(10)